Quanterix completes acquisition of EMISSION iNC. to expand capabilities in ultrasensitive biomarker detection
Acquiring Company
Quanterix
Acquired Company
EMISSION
BillericaGeorgetownOtherHealth CareManufacturingDescription
Quanterix Corporation has announced the acquisition of EMISSION iNC., a company based in Georgetown, TX, specializing in manufacturing dye-encapsulating magnetic beads designed for low and mid-plex assays. This strategic acquisition is aimed at expanding Quanterix's technology stack toward higher multi-plex and multi-omic capabilities, enabling the control of core components and the provision of OEM beads to other platforms.
Quick answer
Quanterix is acquiring EMISSION, announced December 17, 2024. Quanterix is based in Billerica, Massachusetts, United States.
- How much did Quanterix pay for EMISSION?
- The deal value was not disclosed.
- What does Quanterix do?
- Quanterix is a company that’s digitizing biomarker analysis with the goal of advancing the science of precision health.
- Where are Quanterix and EMISSION based?
- Quanterix is based in Billerica, Massachusetts, United States. EMISSION is based in Georgetown, Texas, United States.
- Who are the decision-makers at Quanterix?
- Fundz holds 1 contact at Quanterix. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Other recent acquisitions in Health Care and Manufacturing
Deals where the buyer or target shares a sector with this one, within 45 days, from Fundz verified event records.
- Boston Scientific completes acquisition of Axonics, Inc. to expand into sacral neuromodulation (November 15, 2024)
- Aspen Medical Products Acquires Advanced Orthopaedics to Expand into Bracing and Supports Market (January 29, 2025)
- Revelation Pharma strengthens its nationwide presence in ENT and Animal Health with acquisition of Cascade Specialty Pharmacy (January 22, 2025)
- Eton Pharmaceuticals completes acquisition of Galzin® (zinc acetate) from Teva Pharmaceuticals USA, Inc. to advance treatment for Wilson Disease (January 5, 2025)
- StatLab Medical Products completes acquisition of Especialidades Médicas Myr, S.L. to expand global reach (December 18, 2024)
- Novo Holdings completes acquisition of Catalent, Inc. (December 18, 2024)
Who to call at Quanterix, and when
When Quanterix changes hands, the new owners review vendors, systems and leadership. That is when the door opens.
- An alert the day Quanterix raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Quanterix, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Quanterix. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Quanterix makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Frequently asked
Who acquired EMISSION?
EMISSION was acquired by Quanterix, based in Billerica. The deal was reported on December 17, 2024. Quanterix is a company that’s digitizing biomarker analysis with the goal of advancing the science of precision health. Quanterix is publicly traded (QTRX) and operates in Other.
When did Quanterix acquire EMISSION?
Quanterix's acquisition of EMISSION was reported on December 17, 2024. Quanterix Corporation has announced the acquisition of EMISSION iNC., a company based in Georgetown, TX, specializing in manufacturing dye-encapsulating magnetic beads designed for low and mid-plex assays. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does EMISSION do?
EMISSION iNC. is based in Georgetown, TX, and manufactures large-scale, highly-uniform dye-encapsulating magnetic beads designed for low and mid-plex assays, as well as a mid-plex platform that reads its proprietary beads. It is privately held, operating in Manufacturing, and is based in Georgetown.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.